Propanc Biopharma (PPCB)

• Market cap: $2.4M
• 1 day: -5.26%
• 5 days: 1.95%
• 1 month: -0.81%
• 3 months: -60.61%
• 6 months: -92.77%
• Year to date: -80.78%
• 1 year: -96.17%
• 5 years: -96.17%
• 10 years: -96.17%
• Sector: Healthcare
• Industry: Biotechnology

About: Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.

Employees: 2